首页> 外国专利> TRIPLE VACCINE MADE BY ADDING TETANUMMTOXOID AND DIPHTHERIAATOXOID TO PERTUSSIS HA FRACTION

TRIPLE VACCINE MADE BY ADDING TETANUMMTOXOID AND DIPHTHERIAATOXOID TO PERTUSSIS HA FRACTION

机译:通过将戊二酸和二硫代乙酸添加到百日咳HA组分中制成三联疫苗

摘要

PURPOSE:Title triple vaccine that is composed of cells of Homophilus pertussis, in which the endotoxin, LPF and HSF are reduced or deactivated, tetranus-toxoid and diphtheria-toxoid, thus showing reduced side-effects. CONSTITUTION:The I-phase mold of Homophilus pertussis (vaccine mold) is cultured and the culture filtrate is fractionated using ammonium sulfate and subjected to sucrose density-ingredient centrifugation to reduce largely the endotoxin, LPF and HSF to 1/5 level of that of conventional vaccine. Then, the LPF and HSF remaining in the product mainly containing fractions which are active on HA are deactivated with formaldehyde. Tetanus-toxoide and diphtheriatoxiod are added to the fraction to produce said triple vaccine with reduced toxicity through mass-production processes. The side-effects of conventional triple vaccine is through to be caused by pertussis vaccine and the treatment according to the present invention inhibits the side-effects.
机译:目的:由百日咳嗜血杆菌细胞组成的三联疫苗,其中内毒素,LPF和HSF减少或失活,四核类毒素和白喉类毒素显示出减少的副作用。组成:培养百日咳杆菌的I相霉菌(疫苗霉菌),并用硫酸铵对培养滤液进行分级分离,并进行蔗糖密度成分离心,以将内毒素,LPF和HSF大大降低至内毒素的1/5水平。常规疫苗。然后,将残留在产物中的主要包含对HA具有活性的馏分中的LPF和HSF用甲醛减活。将破伤风毒素和白喉毒素添加到级分中,以通过批量生产过程生产毒性降低的三联疫苗。常规的三联疫苗的副作用是由百日咳疫苗引起的,并且根据本发明的治疗抑制了副作用。

著录项

  • 公开/公告号JPS575203B2

    专利类型

  • 公开/公告日1982-01-29

    原文格式PDF

  • 申请/专利权人

    申请/专利号JP19790048524

  • 发明设计人

    申请日1979-04-21

  • 分类号A61K39/05;A61K39/08;A61K39/095;A61K39/10;A61K39/116;

  • 国家 JP

  • 入库时间 2022-08-22 14:05:42

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号